Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury.
During cardiac ischemia-reperfusion (IR) injury, excessive generation of reactive oxygen species (ROS) and overload of Ca(2+) at the mitochondrial level both lead to opening of the mitochondrial permeability transition (PT) pore on reperfusion. This can result in the depletion of ATP, irreversible oxidation of proteins, lipids, and DNA within the cardiomyocyte, and can trigger cell-death pathways. In contrast, mitochondria are also implicated in the cardioprotective signaling processes of ischemic preconditioning (IPC), to prevent IR-related pathology. Nitric oxide (NO*) has emerged as a potent effector molecule for a variety of cardioprotective strategies, including IPC. Whereas NO* is most noted for its activation of the "classic" soluble guanylate cyclase (sGC) signaling pathway, emerging evidence indicates that NO can directly act on mitochondria, independent of the sGC pathway, affording acute cardioprotection against IR injury. These direct effects of NO* on mitochondria are the focus of this review.
Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New York 14642, USA.
Lindsay S
LS
Burwell
Paul S
PS
Brookes
D000818:Animals; D002316:Cardiotonic Agents / Q000494:pharmacology*; D006801:Humans; D008929:Mitochondria, Heart / Q000187:drug effects*; D009569:Nitric Oxide / Q000494:pharmacology*; D015427:Reperfusion Injury / Q000517:prevention & control*
D002316:Cardiotonic Agents; D009569:Nitric Oxide